INSMED Inc (INSM) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
INSM currently has 212M outstanding shares. with minimal authorized share overhang for future dilution. The company has significantly diluted shareholders by 39.6% over the past 2 years, indicating aggressive capital raising.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Oct 30, 2025 |
10-Q filing | 211.8M shares outstanding |
210M | 0 |
| Aug 07, 2025 |
10-Q filing | 211.4M shares outstanding |
210M | 0 |
| Jun 13, 2025 |
8-K filing: Insmed Incorporated has agreed to sell 7,812,500 shares of common stock to Underwriters at a price of $91.68 per share, resulting in net proceeds of approximately $716.3 million before other offering expenses, and granted the Underwriters a 30-day option to purchase up to an additional 1,171,875 shares of Common Stock. The transaction is expected to close on June 13, 2025. ($716.3M proceeds) |
180M | 0 |
| May 08, 2025 |
10-Q filing | 180.9M shares outstanding |
180M | 0 |
| Feb 20, 2025 |
10-K filing | 164.0M shares outstanding |
160M | 0 |
| Oct 31, 2024 |
10-Q filing | 173.7M shares outstanding |
170M | 0 |
| Aug 08, 2024 |
10-Q filing | 154.7M shares outstanding |
150M | 0 |
| May 30, 2024 |
8-K filing: Insmed Incorporated completed an offering of 14,514,562 shares of common stock at a price of $49.1825 per share, resulting in net proceeds of approximately $713.9 million. ($713.9M proceeds) |
150M | 0 |
| May 09, 2024 |
10-Q filing | 148.5M shares outstanding |
150M | 0 |
| Feb 22, 2024 |
10-K filing | 140.4M shares outstanding |
140M | 0 |
| Oct 26, 2023 |
10-Q filing | 142.9M shares outstanding |
140M | 0 |
| Aug 03, 2023 |
10-Q filing | 137.6M shares outstanding |
140M | 0 |
| May 04, 2023 |
10-Q filing | 136.4M shares outstanding |
140M | 0 |
| Feb 23, 2023 |
10-K filing | 123.0M shares outstanding |
120M | 0 |
| Oct 27, 2022 |
10-Q filing | 135.5M shares outstanding |
140M | 0 |
| Oct 20, 2022 |
8-K filing: Insmed Incorporated has agreed to sell 13,750,000 shares of common stock to Underwriters at an offering price of $20.00 per share, with gross proceeds of $275 million, pursuant to an Underwriting Agreement dated October 19, 2022. ($275.0M proceeds) |
120M | 0 |
| Aug 04, 2022 |
10-Q filing | 119.6M shares outstanding |
120M | 0 |
| May 05, 2022 |
10-Q filing | 118.9M shares outstanding |
120M | 0 |
| Feb 17, 2022 |
10-K filing | 112.1M shares outstanding |
110M | 0 |
| Oct 28, 2021 |
10-Q filing | 117.1M shares outstanding |
120M | 0 |
| Aug 05, 2021 |
10-Q filing | 109.6M shares outstanding |
110M | 0 |
| May 13, 2021 |
8-K filing: Insmed Incorporated closed its underwritten public offering of $575 million aggregate principal amount of 0.75% Convertible Senior Notes due 2028 and a concurrent public offering of 11,500,000 shares of Common Stock. |
100M | 0 |
| May 13, 2021 |
8-K filing: Insmed Incorporated completed a public offering of 11,500,000 shares of common stock at a price of $23.50 per share, resulting in gross proceeds of $287.5 million before deducting underwriting discounts and commissions. ($287.5M proceeds) |
100M | 0 |
| May 06, 2021 |
10-Q filing | 103.0M shares outstanding |
100M | 0 |
| Feb 25, 2021 |
10-K filing | 97.6M shares outstanding |
98M | 0 |
| Oct 29, 2020 |
10-Q filing | 101.6M shares outstanding |
100M | 0 |
| Aug 06, 2020 |
10-Q filing | 96.6M shares outstanding |
97M | 0 |
| May 07, 2020 |
8-K filing: Insmed Incorporated completed an offering of 11,155,000 shares of common stock at a price of $22.0875 per share, resulting in net proceeds of approximately $246.4 million. ($246.4M proceeds) |
90M | 0 |
| Apr 30, 2020 |
10-Q filing | 89.8M shares outstanding |
90M | 0 |
| Feb 25, 2020 |
10-K filing | 84.6M shares outstanding |
85M | 0 |